

Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.
You can purchase shares of LENSAR (NASDAQ:LNSR) through any online brokerage.
Other companies in LENSAR’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
LENSAR has a consensus price target of $11.00.
The stock price for LENSAR (NASDAQ: LNSR) is $5.54 last updated November 5, 2026 at 12:54 PM EST.
There are no upcoming dividends for LENSAR.
LENSAR does not have any upcoming earnings scheduled.
There is no upcoming split for LENSAR.
LENSAR is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to...